DataSheet_9_Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.xlsx
COVID-19, caused by SARS-CoV-2 virus, is a global pandemic with high mortality and morbidity. Limited diagnostic methods hampered the infection control. Since the direct detection of virus mainly by RT-PCR may cause false-negative outcome, host response-dependent testing may serve as a complementary approach for improving COVID-19 diagnosis.
ObjectiveOur study discovered a highly-preserved transcriptional profile of Type I interferon (IFN-I)-dependent genes for COVID-19 complementary diagnosis.
MethodsComputational language R-dependent machine learning was adopted for mining highly-conserved transcriptional profile (RNA-sequencing) across heterogeneous samples infected by SARS-CoV-2 and other respiratory infections. The transcriptomics/high-throughput sequencing data were retrieved from NCBI-GEO datasets (GSE32155, GSE147507, GSE150316, GSE162835, GSE163151, GSE171668, GSE182569). Mathematical approaches for homological analysis were as follows: adjusted rand index-related similarity analysis, geometric and multi-dimensional data interpretation, UpsetR, t-distributed Stochastic Neighbor Embedding (t-SNE), and Weighted Gene Co-expression Network Analysis (WGCNA). Besides, Interferome Database was used for predicting the transcriptional factors possessing IFN-I promoter-binding sites to the key IFN-I genes for COVID-19 diagnosis.
ResultsIn this study, we identified a highly-preserved gene module between SARS-CoV-2 infected nasal swab and postmortem lung tissue regulating IFN-I signaling for COVID-19 complementary diagnosis, in which the following 14 IFN-I-stimulated genes are highly-conserved, including BST2, IFIT1, IFIT2, IFIT3, IFITM1, ISG15, MX1, MX2, OAS1, OAS2, OAS3, OASL, RSAD2, and STAT1. The stratified severity of COVID-19 may also be identified by the transcriptional level of these 14 IFN-I genes.
ConclusionUsing transcriptional and computational analysis on RNA-seq data retrieved from NCBI-GEO, we identified a highly-preserved 14-gene transcriptional profile regulating IFN-I signaling in nasal swab and postmortem lung tissue infected by SARS-CoV-2. Such a conserved biosignature involved in IFN-I-related host response may be leveraged for COVID-19 diagnosis.
History
References
- https://doi.org//10.1007/s00428-021-03053-1
- https://doi.org//10.3389/fmicb.2020.01570
- https://doi.org//10.2214/AJR.20.23418
- https://doi.org//10.1136/bmjopen-2020-047110
- https://doi.org//10.3892/ijmm.2020.4702
- https://doi.org//10.1080/22221751.2020.1747363
- https://doi.org//10.1038/s41598-021-86002-x
- https://doi.org//10.1016/j.cell.2021.01.053
- https://doi.org//10.1038/s41467-021-21289-y
- https://doi.org//10.1126/science.abd4570
- https://doi.org//10.1126/science.abd4585
- https://doi.org//10.1016/j.antiviral.2020.104791
- https://doi.org//10.1146/annurev-virology-092818-015756
- https://doi.org//10.1016/j.chom.2020.05.008
- https://doi.org//10.3390/v12060628
- https://doi.org//10.1101/2021.03.09.434529
- https://doi.org//10.1002/ped4.12226
- https://doi.org//10.1186/s12879-021-05976-1
- https://doi.org//10.1186/s12866-021-02087-4
- https://doi.org//10.1038/s41563-020-00906-z
- https://doi.org//10.1016/j.it.2021.02.003
- https://doi.org//10.1016/j.cell.2020.04.035
- https://doi.org//10.1371/journal.ppat.1009878
- https://doi.org//10.1371/journal.pone.0243270
- https://doi.org//10.1038/s41467-019-08746-5
- https://doi.org//10.1002/0471250953.bi0301s42
- https://doi.org//10.3325/cmj.2020.61.66
- https://doi.org//10.1186/s12918-017-0420-6
- https://doi.org//10.1016/j.cell.2020.04.026
- https://doi.org//10.1093/nar/gks1215
- https://doi.org//10.1016/j.mib.2010.07.001
- https://doi.org//10.3389/fcvm.2020.623012
- https://doi.org//10.1016/j.molcel.2021.04.008
- https://doi.org//10.1016/j.coviro.2011.10.008
- https://doi.org//10.3389/fmicb.2018.03228
- https://doi.org//10.1038/s41564-021-00884-1
- https://doi.org//10.1016/j.isci.2020.101585
- https://doi.org//10.1128/JVI.00709-18
- https://doi.org//10.1016/j.cyto.2016.08.009
- https://doi.org//10.1074/jbc.REV120.012784
- https://doi.org//10.1038/s41421-020-00208-3
- https://doi.org//10.3389/fimmu.2021.666163
- https://doi.org//10.3389/fimmu.2019.00705
- https://doi.org//10.3389/fimmu.2017.00029
- https://doi.org//10.3390/vaccines4030023
- https://doi.org//10.1155/2017/2846928
- https://doi.org//10.15252/embr.201540726
- https://doi.org//10.3389/fimmu.2019.01448
- https://doi.org//10.1038/s41467-019-10970-y
- https://doi.org//10.1186/s40425-019-0635-8
- https://doi.org//10.1007/s00018-020-03671-z
- https://doi.org//10.1083/jcb.202002175
- https://doi.org//10.1016/j.cca.2020.03.009
- https://doi.org//10.1038/s41586-020-2196-x
- https://doi.org//10.7326/M20-1495
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity